Decoy Therapeutics Inc. SEC filings DCOY
Decoy Therapeutics Inc. has 743 filings in SEC EDGAR's recent list, going back to Aug 6, 2014. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 23, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Oct 16, 2026 | — |
| S-1 | Registration statement | Oct 7, 2026 | — |
| 424B3 | Prospectus | Jul 17, 2026 | — |
| S-1 | Registration statement | Jul 10, 2026 | — |
| S-1 | Registration statement | Jun 15, 2026 | — |
| S-8 | Employee stock plan registration | Apr 2, 2026 | — |
| 424B4 | Prospectus | Nov 12, 2025 | — |
| FWP | Free writing prospectus | Nov 10, 2025 | — |
| S-1/A | Amended registration statement | Oct 21, 2025 | — |
| FWP | Free writing prospectus | Sep 26, 2025 | — |
| S-1/A | Amended registration statement | Sep 23, 2025 | — |
| 424B5 | Prospectus supplement | Aug 22, 2025 | — |
| S-3 | Shelf registration | Aug 15, 2025 | — |
| S-1/A | Amended registration statement | Aug 8, 2025 | — |
| FWP | Free writing prospectus | Aug 5, 2025 | — |
| S-1/A | Amended registration statement | Jul 31, 2025 | — |
| S-1/A | Amended registration statement | Jun 16, 2025 | — |
| S-1/A | Amended registration statement | May 22, 2025 | — |
| S-1/A | Amended registration statement | Apr 17, 2025 | — |
| 424B5 | Prospectus supplement | Mar 11, 2025 | — |
| S-1 | Registration statement | Jan 21, 2025 | — |
| 424B3 | Prospectus | Jan 13, 2025 | — |
| S-1 | Registration statement | Dec 16, 2024 | — |
| 424B5 | Prospectus supplement | Jul 25, 2024 | — |
| 424B5 | Prospectus supplement | Jul 22, 2024 | — |
| 424B5 | Prospectus supplement | Jun 17, 2024 | — |
| 424B3 | Prospectus | Jun 7, 2023 | — |
| S-3/A | Filing | Jun 1, 2023 | — |
| S-3 | Shelf registration | May 26, 2023 | — |
| S-8 | Employee stock plan registration | Feb 15, 2023 | — |
| S-3 | Shelf registration | Aug 5, 2022 | — |
| S-3 | Shelf registration | Jun 10, 2022 | — |
| 424B5 | Prospectus supplement | Apr 26, 2022 | — |
| S-8 | Employee stock plan registration | Feb 22, 2022 | — |
| 424B5 | Prospectus supplement | Jul 2, 2021 | — |
| 424B5 | Prospectus supplement | Jul 1, 2021 | — |
| 424B5 | Prospectus supplement | Mar 5, 2021 | — |
| 424B5 | Prospectus supplement | Mar 3, 2021 | — |
| 424B5 | Prospectus supplement | Feb 5, 2021 | — |
| S-3 | Shelf registration | Jan 15, 2021 | — |
| S-8 | Employee stock plan registration | Aug 14, 2020 | — |
| 424B5 | Prospectus supplement | Jul 31, 2020 | — |
| 424B5 | Prospectus supplement | Jul 29, 2020 | — |
| 424B4 | Prospectus | Feb 10, 2020 | — |
| S-1MEF | Filing | Feb 7, 2020 | — |
| S-1/A | Amended registration statement | Feb 6, 2020 | — |
| FWP | Free writing prospectus | Jan 29, 2020 | — |
| S-1/A | Amended registration statement | Jan 28, 2020 | — |
| S-1 | Registration statement | Jan 10, 2020 | — |
| 424B5 | Prospectus supplement | Oct 28, 2019 | — |
| 424B3 | Prospectus | Jun 27, 2019 | — |
| 424B3 | Prospectus | Apr 30, 2019 | — |
| S-3 | Shelf registration | Apr 24, 2019 | — |
| S-4/A | Filing | Apr 18, 2019 | — |
| S-4/A | Filing | Mar 26, 2019 | — |
| S-8 | Employee stock plan registration | Mar 6, 2019 | — |
| S-4 | Registration for a merger or exchange | Feb 14, 2019 | — |
| S-8 | Employee stock plan registration | Mar 7, 2018 | — |
| S-8 | Employee stock plan registration | Mar 8, 2017 | — |
| S-3/A | Filing | Apr 8, 2016 | — |
| S-3 | Shelf registration | Mar 18, 2016 | — |
| S-8 | Employee stock plan registration | Mar 18, 2016 | — |
| S-8 | Employee stock plan registration | Feb 2, 2015 | — |
| 424B4 | Prospectus | Jan 29, 2015 | — |
| S-1MEF | Filing | Jan 28, 2015 | — |
| S-1/A | Amended registration statement | Jan 20, 2015 | — |
| S-1/A | Amended registration statement | Jan 13, 2015 | — |
| S-1 | Registration statement | Dec 29, 2014 | — |
Showing 68 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- DCOY (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Houston, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1615219
- Former names
- Salarius Pharmaceuticals, Inc. (until Jan 9, 2026); Flex Pharma, Inc. (until Jul 22, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.